怡达股份(300721.SZ)：控股子公司拟吸收合并其全资子公司

Core Viewpoint - Yida Co., Ltd. announced the absorption merger of its wholly-owned subsidiary Wanqu Biotechnology (Taizhou) Co., Ltd. by its holding subsidiary Taixing Yida Chemical Co., Ltd. to optimize management structure and improve operational efficiency [1] Group 1 - The merger will result in the cancellation of Wanqu's independent legal status, with all its business, assets, liabilities, personnel, rights, and obligations being legally inherited by Taixing Yida [1] - The merger does not involve any changes to Taixing Yida's company name, registered capital, or equity structure [1]